The Observational Medical Outcomes Partnership (OMOP) is a public-private partnership designed to protect human health by improving the monitoring of drugs for safety and effectiveness. The partnership will conduct a two-year initiative to research methods that are feasible and useful to analyze existing healthcare databases to identify and evaluate safety issues of drugs already on […]
BMA report about pharmacovigilance
Report: pdf file
* PHARMACOVIGILANCE 2020 meeting
15 September 2020, Prague (Czech Republic) Organized by the Institute of Pharmacovigilance, with ISoP’s endorsement. More information is found here: Registration and Programme (in Czech language)
CIEHF webinar “Ensuring the safety of medicines”
9 September 2020, 17:00-18:30 (UK time) Register now!
*ISoP Western Pacific Chapter webinar
Monday 7 September 2020 – 8pm to 9.15 pm NZ time (via Zoom) Covid-19 and pharmacovigilance in the Western Pacific region: International Society of Pharmacovigilance Western Pacific chapter webinar discussion. Register your interest!
*ISoP Africa Chapter webinar
Thursday 3 September 2020 – 12.00 to 14.00 UTC/GMT (via Zoom) Register your interest!
